SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037499
Filing Date
2022-11-14
Accepted
2022-11-14 08:00:54
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20220930.htm   iXBRL 10-Q 1850711
2 EX-31.1 vcnx-ex311_15.htm EX-31.1 22307
3 EX-31.2 vcnx-ex312_13.htm EX-31.2 22358
4 EX-32.1 vcnx-ex321_14.htm EX-32.1 10861
  Complete submission text file 0001564590-22-037499.txt   6172170

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20220930.xsd EX-101.SCH 50066
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20220930_cal.xml EX-101.CAL 31561
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20220930_def.xml EX-101.DEF 151350
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20220930_lab.xml EX-101.LAB 376310
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20220930_pre.xml EX-101.PRE 275584
62 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-10q_20220930_htm.xml XML 907456
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 221380417
SIC: 2834 Pharmaceutical Preparations